GlassScriptPhysician profile
Lauren Leeflang
NPI 1306393145
$5,268.52
in general payments reported to CMS, 2019-2025
17 companies · $727 in 2025
The $727 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,231 · 2022: $1,517 · 2023: $678 · 2024: $1,116 · 2025: $727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,521.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $1,921.61 | 2021-2025 | Cabenuva, Dovato, Apretude |
| Gilead Sciences, INC. | $1,482.13 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $564.35 | 2021-2025 | Zerbaxa, Dificid, Pifeltro |
| Abbvie INC. | $329.87 | 2021-2025 | |
| Janssen Biotech, INC. | $326.38 | 2021-2023 | Symtuza |
| Janssen Products, LP | $314.66 | 2021-2022 | |
| Melinta Therapeutics, LLC | $70.52 | 2021-2024 | Rezzayo, Orbactiv, Kimyrsa |
| Theratechnologies INC. | $54.12 | 2022-2024 | Trogarzo, Egrifta |
| Insmed, INC. | $41.51 | 2024 | Arikayce |
| Astellas Pharma US INC | $31.28 | 2021 | |
| Shionogi INC | $27.30 | 2023 | Fetroja |
| Exact Sciences Corporation | $23.60 | 2024 | Cologuard Collection Kit |
| Lilly USA, LLC | $18.14 | 2025 | Mounjaro |
| Paratek Pharmaceuticals, INC. | $17.20 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.14 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $15.24 | 2021 | |
| Novo Nordisk INC | $13.47 | 2025 | Ozempic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Leeflang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.